SUNPHARMA Can witness Free unadulterated Fall

The stock is weak and more so it has been exposed to the shock of heavy volume price level and now facing rejection at higher level. Let it cross 604.20 level then we can take the trade to ride the profit.
Coronavirus (COVID-19)Fundamental AnalysisindianstocksTechnical IndicatorsNIFTYPHARMApharmaceuticalssensexSUNPHARMATrend Analysis

Also on:

Disclaimer